225 related articles for article (PubMed ID: 29162828)
1. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models.
Mita Y; Nakayama K; Inari S; Nishito Y; Yoshioka Y; Sakai N; Sotani K; Nagamura T; Kuzuhara Y; Inagaki K; Iwasaki M; Misu H; Ikegawa M; Takamura T; Noguchi N; Saito Y
Nat Commun; 2017 Nov; 8(1):1658. PubMed ID: 29162828
[TBL] [Abstract][Full Text] [Related]
2. A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
Misu H; Takamura T; Takayama H; Hayashi H; Matsuzawa-Nagata N; Kurita S; Ishikura K; Ando H; Takeshita Y; Ota T; Sakurai M; Yamashita T; Mizukoshi E; Yamashita T; Honda M; Miyamoto K; Kubota T; Kubota N; Kadowaki T; Kim HJ; Lee IK; Minokoshi Y; Saito Y; Takahashi K; Yamada Y; Takakura N; Kaneko S
Cell Metab; 2010 Nov; 12(5):483-95. PubMed ID: 21035759
[TBL] [Abstract][Full Text] [Related]
3. Selenoprotein P as a significant regulator of pancreatic β cell function.
Saito Y
J Biochem; 2020 Feb; 167(2):119-124. PubMed ID: 31373634
[TBL] [Abstract][Full Text] [Related]
4. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.
Yang SJ; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1325-9. PubMed ID: 21677040
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.
Ishikura K; Misu H; Kumazaki M; Takayama H; Matsuzawa-Nagata N; Tajima N; Chikamoto K; Lan F; Ando H; Ota T; Sakurai M; Takeshita Y; Kato K; Fujimura A; Miyamoto K; Saito Y; Kameo S; Okamoto Y; Takuwa Y; Takahashi K; Kidoya H; Takakura N; Kaneko S; Takamura T
Diabetologia; 2014 Sep; 57(9):1968-76. PubMed ID: 24989996
[TBL] [Abstract][Full Text] [Related]
6. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.
Mohri K; Misu H; Takayama H; Ishii KA; Kikuchi A; Lan F; Enyama Y; Takeshita Y; Saito Y; Kaneko S; Takamura T
Biol Pharm Bull; 2019 Mar; 42(3):373-378. PubMed ID: 30606895
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.
Chadani H; Usui S; Inoue O; Kusayama T; Takashima SI; Kato T; Murai H; Furusho H; Nomura A; Misu H; Takamura T; Kaneko S; Takamura M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547524
[TBL] [Abstract][Full Text] [Related]
8. Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ-specific insulin sensitivity in humans with dyslipidemia and type 2 diabetes.
Takeshita Y; Teramura C; Kamoshita K; Takayama H; Nakagawa H; Enyama Y; Ishii KA; Tanaka T; Goto H; Nakano Y; Osada S; Tanaka Y; Tokuyama K; Takamura T
J Diabetes Investig; 2022 Mar; 13(3):532-542. PubMed ID: 34670012
[TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes.
Misu H; Ishikura K; Kurita S; Takeshita Y; Ota T; Saito Y; Takahashi K; Kaneko S; Takamura T
PLoS One; 2012; 7(4):e34952. PubMed ID: 22496878
[TBL] [Abstract][Full Text] [Related]
10. [Novel strategies that target hepatokines for treatment of type 2 diabetes].
Misu H; Takamura T; Kaneko S
Nihon Rinsho; 2012 Jan; 70(1):157-63. PubMed ID: 22413512
[TBL] [Abstract][Full Text] [Related]
11. AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes.
Jung TW; Lee SY; Hong HC; Choi HY; Yoo HJ; Baik SH; Choi KM
Mol Cell Endocrinol; 2014 Jan; 382(1):66-73. PubMed ID: 24055274
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits.
Saito Y; Misu H; Takayama H; Takashima SI; Usui S; Takamura M; Kaneko S; Takamura T; Noguchi N
Biol Pharm Bull; 2018; 41(5):828-832. PubMed ID: 29709922
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2.
Ye X; Toyama T; Taguchi K; Arisawa K; Kaneko T; Tsutsumi R; Yamamoto M; Saito Y
Commun Biol; 2023 Oct; 6(1):1060. PubMed ID: 37857700
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
Rissanen A; Howard CP; Botha J; Thuren T;
Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
[TBL] [Abstract][Full Text] [Related]
15. Identification of hepatokines involved in pathology of type 2 diabetes and obesity.
Misu H
Endocr J; 2019 Aug; 66(8):659-662. PubMed ID: 31366824
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin secretion.
Sung YY; Lee YS; Jung WH; Kim HY; Cheon HG; Yang SD; Rhee SD
Biochem Biophys Res Commun; 2005 Dec; 338(4):1779-87. PubMed ID: 16288988
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet.
Nakaya K; Kubota N; Takamoto I; Kubota T; Katsuyama H; Sato H; Tokuyama K; Hashimoto S; Goto M; Jomori T; Ueki K; Kadowaki T
Metabolism; 2013 Jul; 62(7):939-51. PubMed ID: 23790528
[TBL] [Abstract][Full Text] [Related]
18. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
19. Selenium-enriched milk proteins and selenium yeast affect selenoprotein activity and expression differently in mouse colon.
Hu Y; McIntosh GH; Le Leu RK; Young GP
Br J Nutr; 2010 Jul; 104(1):17-23. PubMed ID: 20346189
[TBL] [Abstract][Full Text] [Related]
20. BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion.
Goulley J; Dahl U; Baeza N; Mishina Y; Edlund H
Cell Metab; 2007 Mar; 5(3):207-19. PubMed ID: 17339028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
